Follow-The-Filings

AVIR · Atea Pharmaceuticals Inc.

Q3 2023 13F holders

← latest ownership dossier

Ticker
AVIR
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares